The NLRP3 inflammasome is activated in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and its activation status is positively correlated with disease severity and mortality in patients [24]. The gene discussed is NLRP3; the disease is COVID-19.